Related Experiment Videos
Immune-mediated necrotizing myopathy associated with statins
Phyllis Grable-Esposito1, Hans D Katzberg, Steven A Greenberg
1Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. phyllis.grableesposito@va.gov
Muscle & Nerve
|October 9, 2009
Summary
Statin-associated necrotizing myopathy is a rare immune-mediated condition. Patients experience persistent muscle weakness and elevated creatine kinase (CK) levels, responding to immunosuppressive therapy.
Area of Science:
- Neurology
- Immunology
- Pharmacology
Background:
- Statins are widely used cholesterol-lowering drugs.
- Muscle-related side effects, including myopathy, can occur with statin use.
- Rare cases of necrotizing myopathy have been linked to statin treatment.
Observation:
- A study identified 25 patients with statin-associated necrotizing myopathy.
- These patients exhibited persistent muscle weakness and elevated creatine kinase (CK) levels despite statin discontinuation.
- Muscle biopsies revealed necrotizing myopathy without significant inflammation.
Findings:
- Eighty-two percent of patients with necrotizing myopathy had prior statin exposure, significantly higher than other myopathies.
- Twenty-four patients required multiple immunosuppressive agents, and 15 relapsed upon tapering therapy.
- These factors suggest an immune-mediated etiology for statin-associated necrotizing myopathy.
Implications:
- This research highlights a rare but serious adverse effect of statin therapy.
- Early recognition and immunosuppressive treatment are crucial for managing statin-associated necrotizing myopathy.
- Further research into the immune mechanisms underlying this condition is warranted.
Related Concept Videos
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:21Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...